Healthcare -
Biotechnology - NASDAQ - US
$ 0.2625
-3.42 %
$ 16.9 M
Market Cap
-0.44
P/E
GLYC - CASH & EQUIVALENTS
Cash & Equivalents GLYC - GlycoMimetics, Inc.
10.7 M
LAST VALUE
-52.68%
2 YEAR CAGR
-41.63%
5 YEAR CAGR
-15.12%
10 YEAR CAGR